LRMR
Larimar Therapeutics Inc
3.30$
-14.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +17.4% | -1.2% | +8.7% | -14.9% | +225.7% | -63.5% | -1.1% | – | – | – | – | – | |
| – | – | – | – | – | – | -136.5% | – | – | – | – | – | – | |
| – | +60.5% | +21.7% | +53.1% | -29.3% | +92.1% | -0.7% | -12.0% | +92.3% | +32.1% | -57.8% | +11.9% | – | |
| – | -6.4% | +8.0% | +29.6% | -11.6% | +4.8% | +1.8% | -4.6% | +3.3% | +1.7% | +31.0% | +4.4% | – | |
| – | +36.2% | +18.3% | +47.7% | -25.8% | +71.3% | -0.3% | -10.9% | +78.1% | +29.3% | -51.4% | +10.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -1.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.